- no one at GNE cares nor is offended by rainbow flags
- salary is not really considered for layoffs. level is (IC vs front line mgr vs director). the cost difference between someone making, say, $150k a year vs $200k a year is not 33%. When you count in fixed costs, health benefits, office space, car allowance, etc the gap is much less, like 10-15%.
- how flat they want the organization, reducing redundancies and shrinking areas that are no longer relevant is how they TRY to reduce head count
- in theory they TRY to retain the best talent, regardless of salary. however when the changes are massive and many they tend to have more of a sledge-hammer-eliminate-entire-departments mentality.
- in practice this transformation has done a lot to protect ADs and above. Our EC hasn't reduced head count. FAO promoted a bunch of losers (and I mean LOSERS) into AD positions to protect them.
- I agree with many assessments that BioOnc field force should see about a 50% reduction and the home office folks that support and are closest to them will see a significant reduction although not as much. As you move towards more internal, operational and cross functional roles expect some reduction but no where near 50%. This will happen because brands will say "we cut heads so you should too".
I for one got a retention bonus that I have to pay back if I leave before Q4, then that puts me close to the annual bonus in March. It should be a good bonus year. BioSimilars wont really hit our pocket book until next year. I say this soley based on my hunch that it will take some time for Docs to switch to the new products. Plus the severance for a 13+ year employee is pretty rich. Kind of feel I need to ride this pony out. But my dumb luck I'll get laid off when the Trump economy comes crash down under extreme national debt.
Now if only I can plan the layoff to happen right when I get a job offer.